Preserving insulin secretion in Type 2 diabetes mellitus

Area of Science:

• Endocrinology
• Metabolic Diseases
• Diabetes Research

Background:

• Type 2 diabetes mellitus (T2DM) involves insulin resistance and declining beta-cell function.
• Beta-cell dysfunction is increasingly recognized as the primary driver of T2DM progression.
• Factors like glucose toxicity, lipotoxicity, and inflammation accelerate beta-cell decline.

Purpose of the Study:

• To review the role of beta-cell dysfunction in T2DM progression.
• To identify strategies for preserving beta-cell function in T2DM management.
• To evaluate the efficacy of various interventions targeting beta-cell health.

Main Methods:

• Literature review of current evidence on T2DM pathophysiology.
• Analysis of factors contributing to beta-cell dysfunction.
• Evaluation of therapeutic interventions for beta-cell preservation.

Main Results:

• Beta-cell dysfunction, not insulin resistance, is the main driver of T2DM progression.
• Glucose toxicity, lipotoxicity, oxidative stress, and inflammation accelerate beta-cell failure.
• Multiple interventions show promise in preserving beta-cell function.

Conclusions:

• Future T2DM management must prioritize strategies to preserve beta-cell function.
• Lifestyle modifications, specific drug classes, and bariatric surgery show potential.
• Therapeutic insulin remains a vital and physiological treatment option.